Vassee Moorthy

Summary

Publications

  1. doi request reprint MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives
    Vasee S Moorthy
    Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    Vaccine 27:624-8. 2009
  2. pmc Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review
    Vasee S Moorthy
    Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    Malar J 8:23. 2009
  3. ncbi request reprint Meeting on planning Plasmodium vivax vaccine efficacy trials. July 20-21, 2004, Singapore
    Vassee Moorthy
    The PATH Malaria Vaccine Initiative, Bethesda, MD 20814, USA
    Expert Rev Vaccines 5:21-5. 2006
  4. ncbi request reprint Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation
    Vasee Moorthy
    Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, Churchill Hospital, Oxford OX3 7LJ, UK
    Vaccine 25:5115-23. 2007

Detail Information

Publications4

  1. doi request reprint MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives
    Vasee S Moorthy
    Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    Vaccine 27:624-8. 2009
    ..Research into possible interactions between malaria control measures was highlighted as a priority...
  2. pmc Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review
    Vasee S Moorthy
    Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    Malar J 8:23. 2009
    ..There has been variability in the specification of end-points, case definitions, analysis methods and reporting and the relative lack of standardization complicates the ability to make comparative evaluations between trials...
  3. ncbi request reprint Meeting on planning Plasmodium vivax vaccine efficacy trials. July 20-21, 2004, Singapore
    Vassee Moorthy
    The PATH Malaria Vaccine Initiative, Bethesda, MD 20814, USA
    Expert Rev Vaccines 5:21-5. 2006
  4. ncbi request reprint Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation
    Vasee Moorthy
    Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, Churchill Hospital, Oxford OX3 7LJ, UK
    Vaccine 25:5115-23. 2007
    ..While phase IV studies may be necessary to generate some of this information, it is important to design pivotal trials to provide this information to the extent possible...